» Articles » PMID: 13129912

Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Sep 18
PMID 13129912
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is currently considered as an epidemic in the western world, and it represents a major risk factor for life-threatening diseases such as heart attack, stroke, diabetes, and cancer. Taking advantage of DNA microarray technology, we tried to identify the molecules explaining the relationship between obesity and vascular disorders, comparing mRNA expression of about 12,000 genes in white adipose tissue between normal, high fat diet-induced obesity (DIO) and d-Trp34 neuropeptide Y-induced obesity in mice. Expression of monocyte chemoattractant protein-1 (MCP-1) mRNA displayed a 7.2-fold increase in obese mice as compared with normal mice, leading to substantially elevated MCP-1 protein levels in adipocytes. MCP-1 levels in plasma were also increased in DIO mice, and a strong correlation between plasma MCP-1 levels and body weight was identified. We also showed that elevated MCP-1 protein levels in plasma increased the CD11b-positive monocyte/macrophage population in DIO mice. Furthermore, infusion of MCP-1 into lean mice increased the CD11b-positive monocyte population without inducing changes in body weight. Given the importance of MCP-1 in activation of monocytes and subsequent atherosclerotic development, these results suggest a novel role of adiposity in the development of vascular disorders.

Citing Articles

Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias.

Bahrami P, Aromolaran K, Aromolaran A J Cell Physiol. 2025; 240(2):e70012.

PMID: 39943721 PMC: 11822244. DOI: 10.1002/jcp.70012.


A Missing Puzzle in Preclinical Studies-Are CCR2, CCR5, and Their Ligands' Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?-Evidence from Rodent Models and Clinical Studies.

Bober A, Mika J, Piotrowska A Int J Mol Sci. 2024; 25(20).

PMID: 39457105 PMC: 11508617. DOI: 10.3390/ijms252011323.


Hypoxia in Human Obesity: New Insights from Inflammation towards Insulin Resistance-A Narrative Review.

Mirabelli M, Misiti R, Sicilia L, Brunetti F, Chiefari E, Brunetti A Int J Mol Sci. 2024; 25(18).

PMID: 39337290 PMC: 11432683. DOI: 10.3390/ijms25189802.


The Role of Inflammatory Mediators in the Pathogenesis of Obesity.

Bakinowska E, Krompiewski M, Boboryko D, Kielbowski K, Pawlik A Nutrients. 2024; 16(17).

PMID: 39275140 PMC: 11396809. DOI: 10.3390/nu16172822.


Transcriptional control of metabolism by interferon regulatory factors.

Ahmad Z, Kahloan W, Rosen E Nat Rev Endocrinol. 2024; 20(10):573-587.

PMID: 38769435 PMC: 11392651. DOI: 10.1038/s41574-024-00990-0.